The world's biggest vaccine maker resumed exports of COVID-19 doses this month for the first time since April. It has sent about 4 million ...

In May this year, when Covid cases started surging once again in India, SII CEO Adar Poonawalla had said that the SII will continue to scal...

Some rich countries, including those in the European Union, calculated that they had more than enough doses available through bilateral dea...

Known as COVAX, the program was supposed to be a global powerhouse, a multibillion-dollar alliance of international health bodies and nonpr...

The programme aims to distribute enough vaccines to protect at least 20% of the population in 92 low- or medium-income countries.

In a meeting held on Friday, WHO director-general Tedros Adhanom Ghebreyesus spoke about the lack of “political will” for sharing vaccines ...

Gavi, the Vaccine Alliance, says it now projects that the COVAX program can supply just under 1.9 billion doses this year -- including abou...

“Keeping in view the domestic demand, we will not be able to supply doses to the Covax facility till the situation improves in India,” a se...

The doses, to come on stream from October at the earliest, will broaden out the portfolio of vaccines in the Covax scheme, which has so far...

The global programme - co-led by the GAVI vaccine alliance and the World Health Organization (WHO) - said that while it was hoping to resta...

AstraZeneca doses produced under licence in India form the overwhelming bulk of vaccines that COVAX has been anticipating for the initial m...

Vaccines that have not undergone a bridging trial will not be accepted, a senior government official told ET. A bridging trial is a study c...

Questions of how compensation claims would be handled in the event of any serious COVID-19 vaccine side effects, which are likely to be ver...

Wealthy nations have snapped up several billion vaccine doses while some countries in the developing world have little or none. European na...

Johnson & Johnson said on Friday it had submitted for emergency use listing of its COVID-19 vaccine to the World Health Organization (WHO).

The global health body has warned that such deals were driving up vaccine prices and could delay the launch of COVAX, an initiative aimed a...

COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, annou...